SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Harsh D. Amin, Irwin Olsen, Jonathan Knowles, Michel Dard, Nikolaos Donos, A tyrosine-rich amelogenin peptide promotes neovasculogenesis in vitro and ex vivo, Acta Biomaterialia, 2014, 10, 5, 1930

    CrossRef

  2. 2
    Sandro De Falco, Antiangiogenesis therapy: an update after the first decade, The Korean Journal of Internal Medicine, 2014, 29, 1, 1

    CrossRef

  3. 3
    Bénédicte FAUVEL, Aziz Yasri, Antibodies directed against receptor tyrosine kinases, mAbs, 2014, 6, 4, 838

    CrossRef

  4. 4
    Patricia M. LoRusso, Smitha Krishnamurthi, Hagop Youssoufian, Nancy Hall, Floyd Fox, Aruna Dontabhaktuni, Dmitri Grebennik, Scot Remick, Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study, Investigational New Drugs, 2014, 32, 2, 303

    CrossRef

  5. 5
    Guido Giordano, Antonio Febbraro, Michele Venditti, Serena Campidoglio, Nunzio Olivieri, Katia Raieta, Pietro Parcesepe, Giusy Carmen Imbriani, Andrea Remo, Massimo Pancione, Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept, Gastroenterology Research and Practice, 2014, 2014, 1

    CrossRef

  6. 6
    Ping Tang, Li Li, Yan Zhou, Cong-Cong Shen, Yu-Huan Kang, Yu-Qin Yao, Cheng Yi, Lan-Tu Gou, Jin-Liang Yang, The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells, Biotechnology and Applied Biochemistry, 2014, 61, 4
  7. 7
    R.K. Jain, D. Fukumura, D.G. Duda, Pathobiology of Human Disease, 2014,

    CrossRef

  8. 8
    Tetsuhiro Tanaka, Masaomi Nangaku, Angiogenesis and hypoxia in the kidney, Nature Reviews Nephrology, 2013, 9, 4, 211

    CrossRef

  9. 9
    Claudia Peitzsch, Ina Kurth, Leoni Kunz-Schughart, Michael Baumann, Anna Dubrovska, Discovery of the cancer stem cell related determinants of radioresistance, Radiotherapy and Oncology, 2013, 108, 3, 378

    CrossRef

  10. 10
    Géraldine Siegfried, Abdel-Majid Khatib, Processing of VEGF-C and -D by the Proprotein Convertases: Importance in Angiogenesis, Lymphangiogenesis, and Tumorigenesis, Colloquium Series on Protein Activation and Cancer, 2013, 2, 2, 1

    CrossRef

  11. 11
    S. Yasuda, M. Sho, I. Yamato, H. Yoshiji, K. Wakatsuki, S. Nishiwada, H. Yagita, Y. Nakajima, Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo, Clinical & Experimental Immunology, 2013, 172, 3
  12. 12
    W Wang, Y Ma, J Li, H-S Shi, L-Q Wang, F-C Guo, J Zhang, D Li, B-H Mo, F Wen, T Liu, Y-T Liu, Y-S Wang, Y-Q Wei, Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency, Gene Therapy, 2013, 20, 10, 970

    CrossRef

  13. 13
    Edward Chu, An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer, Clinical Colorectal Cancer, 2012, 11, 1, 1

    CrossRef

  14. 14
    Magali Castells, Benoît Thibault, Jean-Pierre Delord, Bettina Couderc, Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death, International Journal of Molecular Sciences, 2012, 13, 12, 9545

    CrossRef

  15. 15
    Sarika Jain, Maureen M. Ward, Jennifer O’Loughlin, Marissa Boeck, Naomi Wiener, Ellen Chuang, Tessa Cigler, Anne Moore, Diana Donovan, Christina Lam, Marta V. Cobham, Sarah Schneider, Paul Christos, Rebecca N. Baergen, Alexander Swistel, Maureen E. Lane, Vivek Mittal, Shahin Rafii, Linda T. Vahdat, Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients, Breast Cancer Research and Treatment, 2012, 132, 1, 235

    CrossRef

  16. 16
    Casey W. Shuptrine, Rishi Surana, Louis M. Weiner, Monoclonal antibodies for the treatment of cancer, Seminars in Cancer Biology, 2012, 22, 1, 3

    CrossRef

  17. 17
    Kenzo Sonoda, RCAS1 is a promising therapeutic target against cancer: its multifunctional bioactivities and clinical significance, Expert Review of Obstetrics & Gynecology, 2012, 7, 3, 261

    CrossRef

  18. 18
    Janice M. Reichert, Eugen Dhimolea, The future of antibodies as cancer drugs, Drug Discovery Today, 2012, 17, 17-18, 954

    CrossRef

  19. 19
    Rajeshwari R. Mehta, Tohru Yamada, Brad N. Taylor, Konstantin Christov, Marissa L. King, Dibyen Majumdar, Fatima Lekmine, Chinnaswamy Tiruppathi, Anne Shilkaitis, Laura Bratescu, Albert Green, Craig W. Beattie, Tapas K. Das Gupta, A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt, Angiogenesis, 2011, 14, 3, 355

    CrossRef

  20. 20
    David Bruce, Peng H Tan, Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?, Expert Opinion on Investigational Drugs, 2011, 20, 10, 1413

    CrossRef

  21. 21
    J. Yao, X. Wu, G. Zhuang, I. M. Kasman, T. Vogt, V. Phan, M. Shibuya, N. Ferrara, C. Bais, Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy, Proceedings of the National Academy of Sciences, 2011, 108, 28, 11590

    CrossRef

  22. 22
    F. Ruffini, C.M. Failla, A. Orecchia, M.R. Bani, A.S. Dorio, C. Fortes, G. Zambruno, G. Graziani, R. Giavazzi, S. D’Atri, P.M. Lacal, Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression, British Journal of Dermatology, 2011, 164, 5
  23. 23
    Peter Carmeliet, Rakesh K. Jain, Molecular mechanisms and clinical applications of angiogenesis, Nature, 2011, 473, 7347, 298

    CrossRef

  24. 24
    Sina Koch, Sònia Tugues, Xiujuan Li, Laura Gualandi, Lena Claesson-Welsh, Signal transduction by vascular endothelial growth factor receptors, Biochemical Journal, 2011, 437, 2, 169

    CrossRef

  25. 25
    Matthew Zibelman, Hossein Borghaei, Anthony J. Olszanski, Antibodies in Cancer Treatment: Early Clinical Development,
  26. 26
    I. Kurth, C. Peitzsch, M. Baumann, A. Dubrovska, The Role of Cancer Stem Cells in Tumor Radioresistance,